+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The factors of disease-free survival in patients with nodal metastases of cutaneous melanoma



The factors of disease-free survival in patients with nodal metastases of cutaneous melanoma



Voprosy Onkologii 50(4): 426-429



The time between primary lesion excision to lymphadenectomy for Cutaneous melanoma was determined in 550 patients. Maximum relapse-free interval was 17.8 years, mean - 16.4 months, with median time of 6.2 months.

(PDF emailed within 1 workday: $29.90)

Accession: 012654306

Download citation: RISBibTeXText

PMID: 15605765


Related references

Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma. American Journal of Surgery 152(4): 371-375, 1986

Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Investigation 29(1): 49-55, 2011

Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival. Dermatologic Surgery 30(10): 1319-1328, 2004

Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. American Journal of Surgery 192(6): 878-881, 2006

Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Yearbook of Dermatology and Dermatologic Surgery 2008: 378-379, 2008

Role of postoperative irradiation for patients with bilateral cervical nodal metastases from cutaneous melanoma: a critical assessment. Head & Neck 32(6): 708-713, 2010

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. American Surgeon 77(8): 1009-1013, 2011

Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. International Journal of Cancer 136(10): 2453-2457, 2015

An incidental finding of a nodal recurrence of cutaneous malignant melanoma after a 45-year disease-free period. Bmj Case Reports 2014: -, 2015

Evaluation on serum 2-5 oligoadenylate synthetase and beta2 microglobulin in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha2A. Anticancer Research 18(3B): 2027-2030, May-June, 1998

Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases. Head & Neck 35(8): 1138-1143, 2014

Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma. International Journal of Dermatology (): -, 2016

Regional non-nodal metastases of cutaneous melanoma. European Journal of Surgical Oncology 12(2): 175-180, 1986

Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival. Nutrition and Cancer: 1-5, 2017

Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A. Anticancer Research 18(3b): 2027-2030, 1998